Needleless connectors for IV catheters

American Journal of Nursing

Volumn 112, Issue 11, 2012, Pages 32-44

  Hadaway, Lynn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATHETER INFECTION; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CROSS INFECTION; EQUIPMENT DESIGN; HUMAN; INFECTION CONTROL; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NURSING; UNITED STATES;

CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CROSS INFECTION; EQUIPMENT DESIGN; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; UNITED STATES; VASCULAR ACCESS DEVICES;

EID: 84868709682     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000422253.72836.c1     Document Type: Article

References (46)

1. Danzig LE, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995;273(23):1862-4.
2. Do AN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999;179(2): 442-8. (Pubitemid 29086647)
3. Field K, et al. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol 2007;28(5):610-3. (Pubitemid 46814555)
4. Jacobs BR, et al. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. JPEN J Parenter Enteral Nutr 2004; 28(2):113-8. (Pubitemid 38365377)
5. Jarvis WR, et al. Health care-associated bloodstream infections associated with negative-or positive-pressure or displacement mechanical valve needleless connectors. Clin Infect Dis 2009; 49(12):1821-7.
6. Kellerman S, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996;129(5):711-7. (Pubitemid 27498281)
7. Maragakis LL, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27(1):67-70. (Pubitemid 46939753)
8. O'Grady N P, et al. Guidelines for the prevention of intravas-cular catheter-related infections, 2011. Atlanta; 2011. http://www.cdc.gov/hicpac/pdf/ guidelines/bsi-guidelines-2011.pdf.
9. Rupp ME, et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis 2007;44(11):1408-14. (Pubitemid 46801581)
10. Salgado CD, et al. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007;28(6):684-8. (Pubitemid 46954754)
11. Schilling S, et al. The impact of needleless connector device design on central venous catheter occlusion in children: a prospective, controlled trial. JPEN J Parenter Enteral Nutr 2006;30(2):85-90. (Pubitemid 44314781)
12. Hadaway L, Richardson D. Needleless connectors: a primer on terminology. J Infus Nurs 2010;33(1):22-31.
13. O'Grady N P, et al. Guidelines for the prevention of intravas-cular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
14. Edmiston CE, Jr., Markina V. Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device. Am J Infect Control 2010;38(6):421-3.
15. Maki DG. In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clin Infect Dis 2010;50(12): 1580-7.
16. Gardner S. Letter to infection control practitioners regarding positive displacement needleless connectors. U.S. Food and Drug Administration; Jul 28, 2010. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm220459.htm.
17. Hadaway L. Technology of flushing vascular access devices. J Infus Nurs 2006;29(3):129-45.
18. Delahanty KM, Myers FE, III. Nursing2007 infection control survey report. Nursing 2007;37(6):28-36.
19. Delahanty KM, Myers FE, III. Nursing2009 I.V. infection control survey report. Nursing 2009;39(12):24-30.
20. Hadaway L. Needleless connectors: improving practice, reducing risks. Journal of the Association for Vascular Access: JAVA 2011;16(1):20-5.
21. Warren DK, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol 2006;27(1):8-13. (Pubitemid 46939744)
22. Hadaway L. Intermittent intravenous administration sets: survey of current practices. Journal of the Association for Vascular Access: JAVA 2007;12(3):143-7. (Pubitemid 47455581)
23. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs 2011;34(1 Suppl):S1-S109.
24. Murga R, et al. Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol 2001;39(6):2294-7. (Pubitemid 32531498)
25. Bouza E, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect 2003;54(4): 279-87. (Pubitemid 37554923)
26. Casey AL, et al. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect 2007;65(3):212-8.
27. Casey AL, et al. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003;54(4):288-93. (Pubitemid 37554924)
28. Lucet JC, et al. Microbiological evaluation of central venous catheter administration hubs. Infect Control Hosp Epidemiol 2000;21(1):40-2.
29. Seymour VM, et al. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000;45(2):165-8.
30. Yebenes JC, et al. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control 2004;32(5):291-5. (Pubitemid 38993372)
31. Marschall J, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29 Suppl 1:S22-S30.
32. Wright MO, et al. Preventing contamination of central venous catheter valves with the use of an alcohol-based disinfecting cap. Am J Infect Control 2012;40(5):e179-e180.
33. Sweet MA, et al. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control 2012 May 8. [Epub ahead of print.]
34. Bowers L, et al. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure Luer-activated devices. J Infus Nurs 2008;31(1): 22-7.
35. Cesaro S, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol 2009;27(12):2059-65.
36. Mitchell MD, et al. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs 2009;65(10):2007-21.
37. Hadaway L. Heparin locking for central venous catheters. Journal of the Association for Vascular Access: JAVA 2006; 11(4):224-31. (Pubitemid 46138759)
38. Goode CJ, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 1991; 40(6):324-30.
39. Peterson F Y, Kirchhoff KT. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung 1991;20(6):631-40.
40. Raad II, et al. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008;21(4):385-92.
41. Simmons S, et al. "Scrub the hub": cleaning duration and reduction in bacterial load on central venous catheters. Crit Care Nurs Q 2011;34(1):31-5.
42. Joint Commission. National patient safety goals. Oakbrook Terrace, IL; 2009. http://www.jointcommission.org/standards- information/npsgs.aspx.
43. Menyhay SZ, Maki DG. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent mi-crobial entry: the promise of a novel antiseptic-barrier cap. Infect Control Hosp Epidemiol 2006;27(1):23-7.
44. Rupp ME, et al. Adequate disinfection of a split-septum needle-less intravascular connector with a 5-second alcohol scrub. Infect Control Hosp Epidemiol 2012;33(7):661-5.
45. Mathew A, et al. Central catheter blood sampling: the impact of changing the needleless caps prior to collection. J Infus Nurs 2009;32(4):212-8.
46. Sherertz RJ, et al. Blood drawn through valved catheter hub connectors carries a significant risk of contamination. Eur J Clin Microbiol Infect Dis 2011;30(12):1571-7.